Berlin, December 16, 2022

WEITNAUER supported Berlin based Belyntic GmbH in the sale of its peptide purification business to NASDAQ listed Mesa Laboratories, Inc., based in Lakewood, Colorado, USA.

The acquired business includes the product "PEC", the first broadly applicable peptide purification kit that uses catch-and-release methods, drastically reducing the need for organic solvents and improving the ecological impact. PEC enables parallel and automated purification of peptides for accelerated drug development and efficient production processes.


WEITNAUER advised the seller Belyntic under the lead of Prof. Dr. Hans-Eric Rasmussen-Bonne, LL.M., Attorney-at-Law (New York), Berlin (M&A, corporate). Further team members were Benedikt Mahr, LL.M., Munich (tax) and Dr. Tobias Krätzschmar, J.D., Attorney-at-Law (Georgia und New York), Munich (IP).


WINHELLER advised Mesa under the lead of attorney Phillipp von Raven (M&A, corporate). Further team members were Dr. Eric Uftring and Lars Gerbe (employment law) as well as Olga Stepanova and Patricia Jechel (IP, patent law).